JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
| $2.44M | ﹤0.01% |
92,591
+77,735
| +523% | +$2.07M |
2022 Q1
1 quarter
|
|
|
CVAC
3227
PUT
DELISTED
CureVac
CVAC
| $2.44M | ﹤0.01% |
+178,900
| New | +$2.96M |
2022 Q2
0 quarters
|
|
3228
Seacoast Banking Corp of Florida
SBCF
$3.16B
| $2.43M | ﹤0.01% |
73,616
-6,992
| -9% | -$234K |
2016 Q4
22 quarters
|
|
|
FSBD
3229
DELISTED
Fidelity Sustainable Core Plus Bond ETF
FSBD
| $2.43M | ﹤0.01% |
+50,000
| New | +$2.46M |
2022 Q2
0 quarters
|
|
3230
Spotify
SPOT
$97.2B
| $2.43M | ﹤0.01% |
25,888
-157,873
| -86% | -$17.8M |
2018 Q2
16 quarters
|
|
|
RDUS
3231
DELISTED
Radius Health, Inc.
RDUS
| $2.42M | ﹤0.01% |
233,851
+40,840
| +21% | +$304K |
2014 Q2
32 quarters
|
|
|
PEPL
3232
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
| $2.42M | ﹤0.01% |
242,510
-127,560
| -34% | -$1.26M |
2022 Q1
1 quarter
|
|
|
CPAA
3233
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
| $2.41M | ﹤0.01% |
+250,000
| New | +$2.43M |
2022 Q2
0 quarters
|
|
|
BRY
3234
DELISTED
Berry Corp
BRY
| $2.41M | ﹤0.01% |
316,543
-235,631
| -43% | -$2.49M |
2018 Q3
15 quarters
|
|
3235
Vishay Precision Group
VPG
$1.05B
| $2.41M | ﹤0.01% |
82,711
-27,521
| -25% | -$843K |
2015 Q4
26 quarters
|
|
3236
AngloGold Ashanti
AU
$48B
| $2.4M | ﹤0.01% |
162,337
-79,676
| -33% | -$1.51M |
2014 Q2
32 quarters
|
|
3237
Ennis
EBF
$571M
| $2.4M | ﹤0.01% |
118,669
+7,079
| +6% | +$128K |
2013 Q2
36 quarters
|
|
3238
PUT
Cognizant
CTSH
$26.4B
| $2.4M | ﹤0.01% |
35,500
-8,000
| -18% | -$612K |
2021 Q1
5 quarters
|
|
|
CHAA
3239
DELISTED
Catcha Investment Corp
CHAA
| $2.39M | ﹤0.01% |
243,729
-66,062
| -21% | -$648K |
2021 Q2
4 quarters
|
|
|
HEES
3240
DELISTED
H&E Equipment Services
HEES
| $2.39M | ﹤0.01% |
82,505
+5,336
| +7% | +$187K |
2015 Q4
26 quarters
|
|
3241
Republic Bancorp
RBCAA
$1.84B
| $2.39M | ﹤0.01% |
49,469
-2,619
| -5% | -$117K |
2013 Q2
36 quarters
|
|
3242
Marcus & Millichap
MMI
$1.08B
| $2.37M | ﹤0.01% |
64,049
-3,474
| -5% | -$151K |
2017 Q4
18 quarters
|
|
|
ROVR
3243
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $2.37M | ﹤0.01% |
629,859
-139,949
| -18% | -$721K |
2021 Q4
2 quarters
|
|
3244
Plexus
PLXS
$7.28B
| $2.36M | ﹤0.01% |
30,070
-45,441
| -60% | -$3.68M |
2015 Q3
27 quarters
|
|
3245
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.2B
| $2.36M | ﹤0.01% |
81,811
+70,272
| +609% | +$2.22M |
2022 Q1
1 quarter
|
|
|
ABB
3246
DELISTED
ABB Ltd
ABB
| $2.36M | ﹤0.01% |
88,178
+52,960
| +150% | +$1.57M |
2013 Q2
36 quarters
|
|
3247
PUT
Boston Scientific
BSX
$61.7B
| $2.35M | ﹤0.01% |
63,200
+44,600
| +240% | +$1.82M |
2020 Q4
6 quarters
|
|
3248
E.W. Scripps
SSP
$254M
| $2.34M | ﹤0.01% |
187,974
+37,424
| +25% | +$598K |
2013 Q2
36 quarters
|
|
|
ELIQ
3249
DELISTED
Electriq Power Holdings, Inc.
ELIQ
| $2.33M | ﹤0.01% |
237,902
-259,141
| -52% | -$2.54M |
2021 Q2
4 quarters
|
|
|
DICE
3250
CALL
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $2.33M | ﹤0.01% |
+150,000
| New | +$2.58M |
2022 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.